ATE219380T1 - Vehikel zum einbringen von nukleinsäuren in zellen - Google Patents
Vehikel zum einbringen von nukleinsäuren in zellenInfo
- Publication number
- ATE219380T1 ATE219380T1 AT96929504T AT96929504T ATE219380T1 AT E219380 T1 ATE219380 T1 AT E219380T1 AT 96929504 T AT96929504 T AT 96929504T AT 96929504 T AT96929504 T AT 96929504T AT E219380 T1 ATE219380 T1 AT E219380T1
- Authority
- AT
- Austria
- Prior art keywords
- cells
- nucleic acids
- vehicles
- introducing nucleic
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Dispersion Chemistry (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL11519995A IL115199A (en) | 1995-09-07 | 1995-09-07 | Composition comprising a polynucleic acid molecule in a liposome and method using said composition |
PCT/IL1996/000101 WO1997010851A2 (en) | 1995-09-07 | 1996-09-05 | Nucleic acid delivery vehicle |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE219380T1 true ATE219380T1 (de) | 2002-07-15 |
Family
ID=11067956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96929504T ATE219380T1 (de) | 1995-09-07 | 1996-09-05 | Vehikel zum einbringen von nukleinsäuren in zellen |
Country Status (8)
Country | Link |
---|---|
US (1) | US6207456B1 (de) |
EP (1) | EP0879062B1 (de) |
JP (1) | JPH11514349A (de) |
AT (1) | ATE219380T1 (de) |
CA (1) | CA2231172A1 (de) |
DE (1) | DE69621953T2 (de) |
IL (1) | IL115199A (de) |
WO (1) | WO1997010851A2 (de) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6890555B1 (en) * | 1992-02-05 | 2005-05-10 | Qlt, Inc. | Liposome compositions of porphyrin photosensitizers |
DE19605548A1 (de) * | 1996-02-15 | 1997-09-04 | Boehringer Ingelheim Int | Zusammensetzung für die Transfektion höherer eukaryotischer Zellen |
FR2751222B1 (fr) | 1996-07-16 | 1998-10-09 | Capsulis | Compositions contenant au moins un acide nucleique et leurs applications dans le domaine biomedical, en particulier en therapie genique |
DE19740092A1 (de) * | 1997-09-12 | 1999-03-18 | Ulrich Dr Med Hengge | Liposomen und Verfahren zur Transfektion von Zellen |
WO1999042091A2 (en) | 1998-02-19 | 1999-08-26 | Massachusetts Institute Of Technology | Use of polycations as endosomolytic agents |
US7276359B1 (en) * | 1998-03-13 | 2007-10-02 | Wyeth | Polynucleotide composition, method of preparation, and use thereof |
IL126681A0 (en) * | 1998-10-21 | 1999-08-17 | Opperbas Holding Bv | Treatment of trauma-related conditions |
EP1361862B1 (de) * | 2001-02-22 | 2007-04-18 | Opperbas Holding B.V. | Durch liposome vermittelte dna verabreichung |
CN1213062C (zh) * | 2001-07-13 | 2005-08-03 | 一泰医药研究(深圳)有限公司 | 序列号13的生物活性肽 |
EP1478659B1 (de) | 2001-07-13 | 2008-11-12 | CMS Peptides Patent Holding Company Limited | Biologisch aktive peptide |
JP2006501838A (ja) * | 2002-10-09 | 2006-01-19 | ファイザー・プロダクツ・インク | 安定化された裸dna組成物 |
US20050042217A1 (en) * | 2003-03-19 | 2005-02-24 | Yan Qi | Specific inhibition of allorejection |
TWI353252B (en) | 2004-04-28 | 2011-12-01 | Cms Peptides Patent Holding Company Ltd | Biologically active peptide vapeehptllteaplnpk der |
EP1778296B1 (de) * | 2004-07-20 | 2012-06-06 | Isogenis, Inc. | Spezifische inhibition von autoimmunität und krankheiten im zusammenhang mit autoantigenen |
RU2423375C2 (ru) | 2005-07-26 | 2011-07-10 | СиЭмЭс ПЕПТАЙДЗ ПЭЙТЕНТ ХОЛДИНГ КОМПАНИ ЛИМИТЕД | Новые биологически активные пептиды и их новое применение |
US20100272769A1 (en) * | 2005-08-03 | 2010-10-28 | Amcol International | Virus-, Bacteria-, and Fungi-Interacting Layered Phyllosilicates and Methods of Use |
US20070031512A1 (en) * | 2005-08-03 | 2007-02-08 | Amcol International Corporation | Virus-interacting layered phyllosilicates and methods of inactivating viruses |
US20080184618A1 (en) * | 2005-08-03 | 2008-08-07 | Amcol International | Virus-Interacting Layered Phyllosilicates and Methods of Use |
EP2395012B8 (de) | 2005-11-02 | 2018-06-06 | Arbutus Biopharma Corporation | Modifizierte siRNA-Moleküle und Verwendungen davon |
US8158152B2 (en) * | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
CA2660804A1 (en) * | 2006-08-31 | 2008-03-06 | Astellas Pharma Inc. | Reverse targeting lipid vesicle |
CN101605534A (zh) | 2006-10-06 | 2009-12-16 | Scil技术股份有限公司 | 脊柱髓核植入物 |
ES2372652T3 (es) * | 2007-05-23 | 2012-01-25 | Amcol International Corporation | Filosilicatos estratificados, que interactúan con el colesterol y métodos para reducir la hipercolesterolemia en un mamífero. |
ES2535419T3 (es) | 2007-12-27 | 2015-05-11 | Protiva Biotherapeutics Inc. | Silenciamiento de expresión de quinasa tipo polo usando ARN interferente |
EP2281041B1 (de) | 2008-04-15 | 2014-07-02 | Protiva Biotherapeutics Inc. | Abdämpfen der csn5 genexpression unter verwendung von interferierender rns |
WO2010033722A2 (en) | 2008-09-17 | 2010-03-25 | Isogenis, Inc. | Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof |
CA2802994A1 (en) | 2010-06-17 | 2011-12-22 | The United States Of America As Represented By The Secretary, National I Nstitutes Of Health | Compositions and methods for treating inflammatory conditions |
CA2826594C (en) | 2011-02-03 | 2019-09-17 | The Government Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services | Multivalent vaccines for rabies virus and filoviruses |
JP2014533953A (ja) | 2011-11-17 | 2014-12-18 | ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 治療用rnaスイッチ組成物及び使用方法 |
US9035039B2 (en) | 2011-12-22 | 2015-05-19 | Protiva Biotherapeutics, Inc. | Compositions and methods for silencing SMAD4 |
KR101839864B1 (ko) | 2012-09-21 | 2018-03-20 | 인텐시티 쎄라퓨틱스, 인코포레이티드 | 암을 치료하는 방법 |
BR112017006679A2 (pt) | 2014-10-02 | 2017-12-26 | Protiva Biotherapeutics Inc | moléculas, composição, partícula, composição farmacêutica, métodos para silenciar a expressão de um gene, usos de uma partícula, métodos para melhorar um ou mais sintomas, métodos para tratar uma infecção, usos de uma composição, método para inibir a replicação do vírus da hepatite d |
CA2982180A1 (en) | 2015-04-09 | 2016-10-13 | Ambika Bumb | Imaging systems and methods using fluorescent nanodiamonds |
US20180245074A1 (en) | 2015-06-04 | 2018-08-30 | Protiva Biotherapeutics, Inc. | Treating hepatitis b virus infection using crispr |
WO2017019891A2 (en) | 2015-07-29 | 2017-02-02 | Protiva Biotherapeutics, Inc. | Compositions and methods for silencing hepatitis b virus gene expression |
US20170360815A1 (en) | 2016-02-25 | 2017-12-21 | Applied Biological Laboratories, Inc. | Compositions and methods for protecting against airborne pathogens and irritants |
SG11201806868TA (en) | 2016-02-25 | 2018-09-27 | Applied Biological Laboratories Inc | Compositions and methods for protecting against airborne pathogens and irritants |
US11041170B2 (en) | 2016-04-04 | 2021-06-22 | Thomas Jefferson University | Multivalent vaccines for rabies virus and coronaviruses |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5283122A (en) | 1984-04-19 | 1994-02-01 | University Of Tennessee Research Corporation | Fused liposome and acid induced method for liposome fusion |
US4789633A (en) * | 1984-04-19 | 1988-12-06 | University Of Tennessee Research Corporation | Fused liposome and acid induced method for liposome fusion |
EP0800830A3 (de) | 1989-11-03 | 1999-03-17 | Vanderbilt University | Verfahren zur in Vivo-Verabreichung von funktionellen fremden Genen |
NZ244306A (en) * | 1991-09-30 | 1995-07-26 | Boehringer Ingelheim Int | Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation |
US5928944A (en) | 1994-02-04 | 1999-07-27 | The United States Of America As Represented By The Department Of Health And Human Services | Method of adenoviral-medicated cell transfection |
-
1995
- 1995-09-07 IL IL11519995A patent/IL115199A/xx not_active IP Right Cessation
-
1996
- 1996-09-05 US US09/029,376 patent/US6207456B1/en not_active Expired - Fee Related
- 1996-09-05 JP JP9512542A patent/JPH11514349A/ja active Pending
- 1996-09-05 AT AT96929504T patent/ATE219380T1/de active
- 1996-09-05 WO PCT/IL1996/000101 patent/WO1997010851A2/en active IP Right Grant
- 1996-09-05 CA CA002231172A patent/CA2231172A1/en not_active Abandoned
- 1996-09-05 EP EP96929504A patent/EP0879062B1/de not_active Expired - Lifetime
- 1996-09-05 DE DE69621953T patent/DE69621953T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH11514349A (ja) | 1999-12-07 |
DE69621953T2 (de) | 2003-01-30 |
DE69621953D1 (de) | 2002-07-25 |
WO1997010851A3 (en) | 1997-06-05 |
WO1997010851A2 (en) | 1997-03-27 |
AU703271B2 (en) | 1999-03-25 |
EP0879062B1 (de) | 2002-06-19 |
US6207456B1 (en) | 2001-03-27 |
IL115199A0 (en) | 1995-12-31 |
CA2231172A1 (en) | 1997-03-27 |
EP0879062A2 (de) | 1998-11-25 |
IL115199A (en) | 2005-05-17 |
AU6888496A (en) | 1997-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE219380T1 (de) | Vehikel zum einbringen von nukleinsäuren in zellen | |
ID18631A (id) | Proses pembuatan asam l-amino melalui fermentasi | |
ID21045A (id) | Asam amino termodifikasi, obat-obatan yang mengandung senyawa ini dan proses pembuatannya | |
ATE237312T1 (de) | In liposomen verkapselte nukleinsäurekomplexe | |
ID18399A (id) | Proses untuk pembuatan serat-serat berikatan silang asam polikarboksilat yang terpisah-pisah dengan bau yang berkurang dan kecermerlangan yang ditingkatkan | |
AU4981101A (en) | Subtilisin variants | |
AU4567499A (en) | Novel mtbx protein and nucleic acid molecules and uses therefor | |
WO1998021328A3 (en) | Human proteins having transmembrane domains and dnas encoding these proteins | |
WO1998055508A3 (en) | HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS | |
ES2133813T3 (es) | Cadenas de lamininas: diagnostico y uso terapeutico. | |
PL336983A1 (en) | Compounds, their production and application as carriers of nucleic acids in cells | |
WO1999025878A3 (en) | Methods for modulating and identifying cellular senescence | |
TR199802394A3 (tr) | Proteinleri stabilize etmek için gelistirilmis proses. | |
ZA888396B (en) | Process for the production of biodegradable microcapsules of water-soluble peptides and proteins,and microcapsules obtained by this process | |
NZ292565A (en) | Production of stabilised complement protein-3 convertase | |
BR9912455A (pt) | ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória | |
WO1997009420A3 (en) | Dna sequences coding for a human metalloproteinase and variants thereof | |
IL138216A0 (en) | Novel fdrg protein and nucleic acid molecules and uses therefor | |
FI964186A (fi) | Ei-liittävät gp350/220-variantit | |
DK0939769T3 (da) | Vertebrat-Smoothened-proteiner | |
ID17326A (id) | Turunan-turunan asam 4-arilbutirat tersubstitusi sebagai inhibitor-inhibitor matriks metalloprotease | |
ES2189014T3 (es) | Procedimiento para insomerizacion de alcoholes alilicos. | |
PL320084A1 (en) | Nucleic acids of amino acid type | |
EP1071749A4 (de) | Neues lrsg-protein und nukleinsäuremoleküle sowie deren verwendung | |
AU5178698A (en) | Novel serine protease inhibitor nucleic acid molecules, proteins and uses hereof |